cyclin-dependent kinase-like 5 deficiency disorder

Drug Newly Approved Seizures

Ztalmy to treat seizures

                    Drug Approval Name: Ztalmy Indications: To treat seizures in cyclin-dependent kinase-like 5 deficiency disorder Active Ingredient: ganaxolone Company: Marinus Pharmaceuticals, Inc. Approval Date: 3/18/2022 Learn more: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215904s000lbl.pdf